Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01893021|
Recruitment Status : Completed
First Posted : July 8, 2013
Last Update Posted : February 4, 2015
The purpose of this study is to understand the family planning needs and practices of postpartum Malawian women, with a focus on long-acting reversible contraception (LARC).
- Postpartum women who are older, who have a history of unintended pregnancy, who do not desire another child within 2 years, and who were counseled about LARC during their pregnancy are more likely to have interest in using LARC.
- Postpartum women who are older are more likely to be aware of LARC methods.
- HIV+ postpartum Malawian women will have similar knowledge about LARC as postpartum Malawian women who are HIV-.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||634 participants|
|Official Title:||Family Planning Knowledge, Attitudes, and Practices of HIV+ and HIV- Postpartum Malawian Women|
|Study Start Date :||May 2013|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
|Postpartum Malawian women|
- Knowledge about the intrauterine device (IUD) and contraceptive implant [ Time Frame: Upon enrollment ]A 14-question test about the IUD and implant will be administered to all study participants upon enrollment.
- Proportion of women using intrauterine device (IUD) and contraceptive implant [ Time Frame: 3, 6, and 12 months postpartum ]We will compare the proportions of HIV+ and HIV- women who are using the IUD and implant at 3, 6, and 12 months postpartum.
- Barriers to receiving intrauterine device (IUD) and contraceptive implant [ Time Frame: Up to 12 months postpartum ]Descriptive statistics will be used to analyze the reasons given for not receiving the IUD or implant at 3, 5, and 12 months postpartum if a woman had wanted to use it.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01893021
|Bwaila Maternity Hospital|
|Principal Investigator:||Jennifer Tang, MD, MSCR||University of North Carolina, Chapel Hill|
|Study Director:||Mina Hosseinipour, MD, MPH||University of North Carolina, Chapel Hill|